- Experience. Mayo Clinic is a leading treatment center for people with primary sclerosing cholangitis. Each year since 2010, Mayo Clinic specialists have cared for more than 1,600 patients with cholangitis, many of whom had primary sclerosing cholangitis or associated complications.
- Nationally recognized expertise. Liver specialists at Mayo Clinic have developed several mathematical models that assess the severity of certain liver diseases. These models help doctors determine where a person ranks on the priority list for a transplant.
- Pioneers in research. Many Mayo Clinic doctors are involved in clinical trials of new medications for primary sclerosing cholangitis. Researchers at Mayo Clinic are also studying the DNA of people with primary sclerosing cholangitis in hopes of identifying genes that increase the risk of the disease and predict its course.
Liver transplant. Mayo Clinic transplant specialists have performed many transplants in people who have primary sclerosing cholangitis. People with primary sclerosing cholangitis who have liver transplants generally have high survival rates — 80 to 85 percent after five years on average. Recipients of liver transplants at Mayo Clinic have above-average survival rates.
Mayo Clinic is also one of the few medical centers in the country to offer liver transplants as a treatment option for bile duct cancer, which develops at much higher rates among people with primary sclerosing cholangitis than in the general population.
Mayo Clinic in Rochester, Minn., ranks No. 1 for digestive disorders in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Scottsdale, Ariz., and Mayo Clinic in Jacksonville, Fla., are ranked among the Best Hospitals for digestive disorders by U.S. News & World Report. Mayo Clinic also ranks among the Best Children's Hospitals for digestive disorders.
Learn more about the Liver Transplant Program's expertise and rankings.
July 07, 2017
- Lazaridis KN, et al. Primary sclerosing cholangitis. New England Journal of Medicine. 2016;375:1161.
- Kowdley KV. Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis. http://www.uptodate.com/home. Accessed Nov. 11, 2016.
- Lindor KD, et al. ACG clinical guideline: Primary sclerosing cholangitis. American Journal of Gastroenterology. 2015;110:646.
- Primary sclerosing cholangitis (PSC). American Liver Foundation. http://www.liverfoundation.org/abouttheliver/info/psc/. Accessed Nov. 11, 2016.
- Longo DL, et al. Diseases of the gallbladder and bile ducts. In: Harrison's Principles of Internal Medicine. 18th ed. New York, N.Y.: The McGraw Hill Companies; 2012. http://www.accessmedicine.com. Accessed Nov. 11, 2016.
- Kowdley KV. Primary sclerosing cholangitis: Epidemiology and pathogenesis. http://www.uptodate.com/home. Accessed Nov. 11, 2016.
- Kowdley KV. Primary sclerosing cholangitis: Management. http://www.uptodate.com/home. Accessed Nov. 11, 2016.
- Beuers U, et al. Pruritus in cholestasis: Facts and fiction. Hepatology. 2014;60:399.
- Poupon R. Pruritus associated with cholestasis. http://www.uptodate.com/home. Accessed Nov. 11, 2016.
- Brown A. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Nov. 3, 2016.
- Jopson L, et al. Understanding and treating fatigue in primary biliary cirrhosis and primary sclerosing cholangitis. Clinical Liver Disease. 2016;20:131.
- Primary sclerosing cholangitis (PSC). American College of Gastroenterology. http://patients.gi.org/topics/primary-sclerosing-cholangitis-psc/. Accessed Nov. 16, 2016.
- Liver health and wellness. American Liver Foundation. http://www.liverfoundation.org/abouttheliver/liverhealth/. Accessed Nov. 16, 2016.
- Medications and the liver. American College of Gastroenterology. http://patients.gi.org/topics/medications-and-the-liver/. Accessed Nov. 16, 2016.
- Picco MF (expert opinion). Mayo Clinic, Rochester, Minn. Nov. 20, 2016.
Primary sclerosing cholangitis